Drug intelligence / Profile preview

HY-07170702

Development stage: Unknown
Lead developer: Hefei Medical and Pharmaceutical
Modality: Small Molecules
Administration: Topical

Overview

HY-07170702 is a small molecule drug developed as a topical ointment for dermatological use. It is currently under investigation for the treatment of atopic dermatitis, with its primary therapeutic focus on immune system diseases, congenital disorders, and skin and musculoskeletal diseases. The drug has reached IND (Investigational New Drug) approval status in China but has not yet advanced beyond early clinical development. Its precise mechanism of action and molecular targets have not been publicly disclosed[1][2].

Beyond the preview

Go deeper on HY-07170702.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HY-07170702.

Explore the full profile